Back to Journals » Blood and Lymphatic Cancer: Targets and Therapy » Volume 9

Review

IDH1-mutated relapsed or refractory AML: current challenges and future prospects

       
Total article views   HTML views PDF downloads Totals
8,490 Dovepress* 8,490+ 2,252 10,742
Totals 8,490 2,252 10,742
*Since 27 June 2019
Total mentioned Facebook Delicious Reddit Twitter Others
23 0 0 0 7 16

View citations on Google Scholar